Bisphosphonate risedronate prevents bone loss in women with artificial menopause due to chemotherapy of breast cancer: a double-blind, placebo-controlled study. - Delmas,P.D.; Balena,R.; Confravreux,E.; Hardouin,C.; Hardy,P.; Bremond,A. (J Clin Oncol, 1997)